Early switch from intravenous to oral antibiotic therapy in patients with cancer who have low-risk neutropenic sepsis (the EASI-SWITCH trial): study protocol for a randomised controlled trial

Early switch from intravenous to oral antibiotic therapy in patients with cancer who have low-risk neutropenic sepsis (the EASI-SWITCH trial): study protocol for a randomised controlled trial

Abstract Background Neutropenic sepsis remains a common treatment complication for patients receiving systemic anti-cancer treatment. The UK National Institute for Health and Care Excellence have not recommended switching from empirical intravenous antibiotics to oral antibiotics within 48 h for pat...

Full description

Bibliographic Details
Main Authors: Caroline Forde, Ronan McMullan, Mike Clarke, Richard H. Wilson, Ruth Plummer, Margaret Grayson, Cliona McDowell, Ashley Agus, Annmarie Doran, Danny F. McAuley, Anne L. Thomas, Rosemary A. Barnes, Richard Adams, Ian Chau, Vicky Coyle
Format: Article
Language:English
Published: BMC 2020-05-01
Series:Trials
Subjects:
Neutropenic sepsis
Low risk
Oral antibiotics
Randomised controlled trial
Non-inferiority
Cancer
Online Access:http://link.springer.com/article/10.1186/s13063-020-04241-1

Internet

http://link.springer.com/article/10.1186/s13063-020-04241-1

Similar Items